Literature DB >> 3708942

Cyclosporine nephrotoxicity in the Fischer rat.

R Verani.   

Abstract

Male Fischer rats received daily intraperitoneal injections of cyclosporine (IV preparation containing CsA + cremophor) diluted in NaCl or in NaCl + cremophor. At the dose of 100 mg and 50 mg/kg/day the animals developed seizures, motor weakness and died at 4-7 days. Light microscopy at 7 days in these rats showed diffuse vacuolization of all segments of the proximal tubules which was very extensive in the outer stripe. At the dose of 25 mg and 15 mg/kg/day animals were free of symptoms and were sacrificed at day 15 for functional and histological studies. Light and electron microscopy showed cytoplasmic vacuolization in all segments of the proximal tubules. Crystal structures were observed in the experimental animals as well as in the control group that received cremophor + NaCl. The CsA blood levels were at the range of 134-236 ng/ml. Reduction of the glomerular filtration rate was observed in experimental animals as compared with the controls. We concluded that CsA is not the cause of an interstitial nephritis in the Fischer rats and that CsA is nephrotoxic to all segments of the proximal tubules. The cremophor is the cause of the crystal structures seen in the proximal tubules.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708942

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  Cyclosporine A reduces dendritic outgrowth of neuroblasts in the subgranular zone of the dentate gyrus in C57BL/6 mice.

Authors:  In Koo Hwang; Sun Shin Yi; Jae Hoon Shin; Ki-Yeon Yoo; Jung Hoon Choi; Choong Hyun Lee; Je Kyung Seong; Yeo Sung Yoon; Jeong Ho Park; Moo-Ho Won
Journal:  Neurochem Res       Date:  2009-10-25       Impact factor: 3.996

2.  Influence of enalapril on experimental cyclosporin A nephrotoxicity.

Authors:  A Anarat; A Noyan; G Gonlusen; N Duman; D Tuncer
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

3.  Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.

Authors:  Karl Henrik Johannes Ehinger; Magnus Joakim Hansson; Fredrik Sjövall; Eskil Elmér
Journal:  Clin Drug Investig       Date:  2013-01       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.